#United States #New York #Class Action #Gross Law Firm #Novo Nordisk

Class Action Filed Against Novo Nordisk A/S

On September 4, 2025, The Gross Law Firm announced a class action lawsuit against Novo Nordisk A/S (stock symbol: NVO) in response to shareholder grievances regarding misleading statements about the company's growth potential. The claims suggest that while Novo Nordisk projected a robust future, they simultaneously concealed crucial negative aspects that could affect the company’s market performance.

Understanding the Allegations

According to the complaint, the defendants allegedly made overwhelmingly positive assertions to investors during the class period from May 7 to July 28, 2025, while failing to disclose materially adverse information. Specifically, they overstated the company’s ability to tap into the compounded market for their GLP-1 products like Wegovy and Ozempic. The complaint contends that Novo misjudged the true impact of the personalization exception to the compounded GLP-1 exclusion and overestimated how likely patients would be to choose their branded alternatives.

On July 29, 2025, after disappointing news about the company’s projections, Novo Nordisk retracted its previously optimistic sales and profit outlook, citing lower growth expectations for the second half of the year. This news caused a dramatic drop in the stock price, decreasing from $69.00 to $53.94 per share in just one day, equating to a staggering fall of approximately 21.83%.

Important Dates

Shareholders are urged to join the class action lawsuit by the September 30, 2025, deadline. Those who participated in purchasing shares during the specified timeframe are eligible to register and potentially serve as a lead plaintiff. It's important to note that being appointed as a lead plaintiff is not a requirement for any shareholders wishing to claim recovery.

Next Steps for Interested Shareholders

Once registered, shareholders will be enrolled in a portfolio monitoring program designed to provide consistent status updates throughout the litigation. This is an opportunity for shareholders to stay informed about the class action status and to know any critical developments as the case unfolds.

The process for registering is straightforward. Interested shareholders can fill out their information through the link provided by The Gross Law Firm and receive updates directly to their email. The firm has made it clear that there are no costs or obligations for shareholders who wish to participate.

Why Choose Gross Law Firm?

The Gross Law Firm is a well-regarded national class action firm committed to protecting the rights of investors. They focus on ensuring that companies comply with ethical business practices while actively seeking recovery for investors who have experienced losses due to fraudulent or deceptive actions by corporations. Their mission emphasizes the importance of responsible corporate citizenship and the need for accountability among publicly traded companies.

For further details or to register, shareholders can contact The Gross Law Firm directly. With their expertise in handling class action lawsuits, they are equipped to navigate the complexities of this case and represent the interests of affected investors.

Contact Information

To get in touch with The Gross Law Firm, call (646) 453-8903 or email [email protected]. They are located at 15 West 38th Street, 12th floor, New York, NY, 10018. For more information, visit their website at Gross Law Firm. This will allow shareholders to take the necessary steps to protect their investments as the lawsuit progresses.